cp wire

CP Wire Articles

CytoReason: Machine-Learning Findings Reveal New Information That Might Lead to Improved Immunotherapy for Refractory Melanoma Patients


New findings presented on 10/16/18 by CytoReason reveals possible new cellular players in the tumor microenvironment that could impact the treatment process for the most in-need patients –... read more

Tue, 10/16/18 - 09:38 am
ENDRA Life Sciences Receives Canadian Approval for Human Studies of its Taeus Device to Detect Non-Alcoholic Fatty Liver Disease
  • Non-Alcoholic Fatty Liver Diesease affects over 1 billion people globally
  • TAEUS provides information previously only available via CT and MRI cheaper and at the point of care
    • ... read more
Tue, 10/16/18 - 09:19 am
Microbiome Report for Week Ending 10/6/18

Rebiotix Clinical, Microbiome Data From First-In-... read more

Sat, 10/13/18 - 04:34 pm
Bacteriophage Company AmpliPhi Bioscience Prices $6.6 Million Public Offering

AmpliPhi Biosciences Corporation (NYSE AMERICAN: APHB) announced on 10/12/18 the pricing of an underwritten public offering of 16,537,500 shares of its common stock (or pre-funded warrants to... read more

Fri, 10/12/18 - 09:36 am
Bristol-Myers Squibb's Opdivo Misses Primary Endpoint in Ph III Study in Small Cell Lung Cancer

Bristol-Myers Squibb Company (NYSE:BMY) announced on 8/12/18 topline results from the Phase 3 CheckMate -331 study evaluating Opdivo (nivolumab) versus the current standard of care, topotecan or... read more

Fri, 10/12/18 - 09:23 am

Pages